Mps1-IN-2
目录号: PL07531 纯度: ≥98%
CAS No. :1228817-38-6
商品编号 规格 价格 会员价 是否有货 数量
PL07531-5mg 5mg ¥1224.00 请登录
PL07531-10mg 10mg ¥2188.36 请登录
PL07531-50mg 50mg ¥6429.09 请登录
PL07531-100mg 100mg ¥11498.18 请登录
PL07531-200mg 200mg 询价 询价
PL07531-500mg 500mg 询价 询价
PL07531-10mM*1mLinDMSO 10mM*1mLinDMSO ¥1346.40 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
Mps1-IN-2
中文别名
9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-B][1,4]二氮杂卓-6(7H)-酮;Mps1-in-2 抑制剂;Mps1-IN-2;9-环戊基-2-[[2-乙氧基-4-(4-羟基哌啶-1-基)苯基]氨基]-5-甲基-8,9-二氢-5H-嘧啶并[4,5-b][1,4]二氮杂卓-6(7H)-酮
英文名称
Mps1-IN-2
英文别名
Mps1-IN-2;Msp1-IN-2;9-Cyclopentyl-2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,7,8,9-tetrahydro-5-methyl-6H-pyrimido[4,5-b][1,4]diazepin-6-one;MPS1IN2;9-Cyclopentyl-2-(2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenylamino)-5-methyl-8,9-dihydro-5H-pyrimido[5,4-b][1,4]diazepin-6(7H)-one;9-cyclopentyl-2-[2-ethoxy-4-(4-hydroxypiperidin-1-yl)anilino]-5-methyl-7,8-dihydropyrimido[4,5-b][1,4]diazepin-6-one;9-cyclopentyl-2-{[2-ethoxy-4-(4-hydroxypiperidin-1-yl)phenyl]amino}-5-methyl-5H,6H,7H,8H,9H-pyrimido[4,5-b][1,4]diazepin-6-one;Scaffold, B13;BDBM36486;BCP19164
Cas No.
1228817-38-6
分子式
C26H36N6O3
分子量
480.60
包装储存
Powder -20°C 3 years;4°C 2 years
产品详情
Mps1-IN-2 是一种有效的,选择性的,ATP 竞争性的 Mps1/Plk1 双重抑制剂,对 Mps1 的 IC50 和 Kd 值分别为 145 nM 和 12 nM,对 Plk1 的 Kd 值为 61 nM。
生物活性
Mps1-IN-2 is a potent, selective and ATP-competitive dual Mps1/Plk1 inhibitor, with an IC 50 and a K d of 145 nM and 12 nM for Mps1 and a K d of 61 nM for Plk1.
性状
Solid
IC50 & Target[1][2]
Mps1 12 nM (Kd) GAK 140 nM (Kd)
体外研究(In Vitro)
Mps1-IN-2 is a potent, selective and ATP-competitive Mps1 kinase inhibitor, with an IC50 and a Kd of 145 nM and 12 nM. Mps1-IN-2 also shows high affinity for PLK1 and GAK with Kds of 61 and 140 nM, respectively, but shows little or no inhibition on other 352 member kinases. Mps1-IN-2 can induces bypass of a checkpoint-mediated mitotic arrest in U2OS cells. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Kwiatkowski N, et al. Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function. Nat Chem Biol. 2010 May;6(5):359-68.
溶解度数据
In Vitro: DMSO : 13.33 mg/mL (27.74 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2